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ABSTRACT 
Objective: To develop a comprehensive value set for encoding adverse reactions in the allergy 
module of an electronic health record (EHR). 
Materials and Methods: We analyzed 2,471,004 adverse reactions stored in Partners 
Healthcare’s enterprise-wide allergy repository (PEAR) of 2.7 million patients.  Using the 
Medical Text Extraction, Reasoning, and Mapping System (MTERMS) system we processed 
both structured and free-text reaction entries and mapped these to SNOMED-CT. We then 
calculated the frequencies of reaction concepts, compared our value set to two external value 
sets, and then created an integrated value set. Lastly, we examined the presence of severe 
reactions and hypersensitivity reactions (HSRs) in our data. 
Results: We identified 786 reaction concepts in PEAR. Most reported reactions were rash 
(14.0%), hives (8.2%), gastrointestinal irritation (5.5%), itching (3.2%) and anaphylaxis (2.5%). 
Mapping of Partners’ value set to two other external sets identified 222 concepts that could be 
partially matched and 135 concepts that were missing.  After incorporating missing and partial 
matches from external value sets, and removing duplicate concepts, our integrated value set 
included 1105 concepts.  The presence of severe reactions was limited in both external sets.  
Hypersensitivity reactions represented roughly 20% of the reactions within our data.  
Conclusion: We developed a value set for adverse reactions using a large dataset from one 
health system, enriched by reactions from two large external resources. This value set included 
severe and hypersensitivity reactions.  We hope this work will improve reaction documentation 
and allergy-related clinical decision support. 
 
OBJECTIVE, BACKGROUND, AND SIGNIFICANCE 
 
Adverse reactions to foods, pharmaceuticals, and diagnostic products cause significant costs, 
morbidity and mortality in our healthcare system[1-3]. Adverse drug reactions (ADRs) have 
been reported to affect up to 10-20% of hospitalized patients and 25% of outpatients[4-6].  Some 
reactions, while rare, can be life threatening, for example toxic epidermal necrolysis (TEN), 
Stevens-Johnson syndrome (SJS), and immune hepatitis. In the United States, it has been 
estimated that nearly 1 in 300 hospitalized patients dies from an ADR every year[1]. Accurate 
documentation of a patient's adverse reactions to medications, products, or foods in the electronic 
health record (EHR) represents an important part of patient safety. 
 
Allergy modules within EHRs provide a location for clinicians to document patients’ adverse 
reactions. Although such modules use the term “allergy”, many reactions entered in the allergy 
module are not immunologically mediated, though non-immunologically mediated reactions 
such as intolerances, toxicities, and idiosyncratic and pseudoallergic reactions can also be 
clinically important and often documented here. In fact, it is estimated that only about 5-10% of 
adverse reactions to drugs are allergic (immune-mediated)[7]. Some EHR systems provide coded 
options in the allergy module for clinicians to indicate a reaction as an allergy, intolerance, or 
contraindication, but studies have found that reaction type and classification are poorly 
understood by clinicians[8]. In addition, in most EHR systems, code sets for reactions are 
typically provided by third-party content vendors and may vary considerably based on the 
vendor and/or local management of terminologies. While useful, they are often limited in the 
number and granularity of reactions they contain, requiring users to enter a free-text reaction 
when the reaction they are looking for is missing. These free-text entries require information 
technologies such as natural language processing (NLP) to convert them to a coded form for 
subsequent automated processing.  
 
Most prior efforts in standard terminologies have focused on capturing adverse events caused by 
drugs or devices for reporting [9 10] and pharmacovigilance purposes[11], rather than for clinical 
documentation in EHR systems. The World Health Organization Adverse Reaction Terminology 
(WHO-ART)[12] and Medical Dictionary for Regulatory Activities (MedDRA)[13] are used by 
pharmaceutical manufacturers for reporting adverse drug events (ADEs) to regulatory agencies. 
As they are mainly for reporting purposes, more clinical terminologies such as SNOMED CT 
have been suggested (e.g., by HL7 [14]) to encode reactions to an allergen or substance in EHRs. 
It is also worth mentioning that the International Classification of Diseases, Clinical 
Modification (ICD-CM) has been used to encode ADEs and hypersensitivity reactions as well 
with codes for rash, angioedema, Steven’s Johnson syndrome and E-Codes to specify allergens 
[15-17].  
 
Recently, an Adverse Clinical Reaction value set using SNOMED CT codes was provided by the 
National Library of Medicine (NLM) Value Set Authority Center (VSAC) with the support of 
the Federal Health Information Modeling and Standards (FHIMS) program. VSAC provides 
official versions of value sets used in clinical quality measures[18]. It also incorporates value 
sets for other use cases. The current published value set was comprised of reactions collected 
from Intermountain Healthcare, Kaiser Permanente, and the Veterans Administration’s systems, 
based on reported frequencies. The value set spans 599 concepts stemming from multiple 
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hierarchies within SNOMED CT. To date, there are no published studies that perform external 
validation of this value set.  
 
Therefore, we developed a new value set, including analysis of a large number of allergy entries 
from the Partners federated hospital/provider network EHR which have been used for some time, 
and then compared it to other value sets, to create a comprehensive value set. We use a NLP tool 
called the Medical Text Extraction, Reasoning, and Mapping System (MTERMS)[19 20] to 
process and map reaction terms to the Systematic Nomenclature of Medicine-Clinical Terms 
(SNOMED CT).  Feasibility of this has been demonstrated in prior work on encoding food 
allergens[21], and extracting allergy information from clinical notes[20].   
 
MATERIALS, METHODS, AND RESULTS 
Our approach included of two phases (Figure 1). The first phase focused on processing reaction 
entries using NLP, creating a comprehensive reaction lexicon and mapping reactions to 
SNOMED-CT concepts. In the second phase, we calculated the frequencies of reaction concepts 
in our data set. We then compared our value set to FHIMS and a value set of reactions provided 
by the University of Nebraska Medical Center (UNMC), to create an integrated value set. Lastly, 
we examined the presence of severe reactions across each value set and the presence of 
hypersensitivity reactions (HSRs) in our own data. As our methods involved multiple steps and 
each step generated corresponding results, we present them in one section accordingly.  
 
 
Figure 1. Overview of Methods 
*PEAR: Partners Enterprise Allergy Repository 
**MTERMS: Medical Text Extraction, Reasoning and Mapping System  
***HSR: Hypersensitivity reactions 
 
Definitions 
Reactions are described at the entry, term, and concept level. We defined an “entry” as a word(s), 
phrase(s) or sentence(s) entered by a clinician into the reaction field of a patient’s allergy record. 
A “term” was the portion of a reaction entry corresponding to the actual reaction, which is not 
normalized and may contain misspellings, acronyms, or syntactic variations. A “concept” was a 
collection of synonymous terms that represent a specific reaction. We defined a “value set” as a 
list of specific numerical values (codes) and human-readable names (concepts) derived from a 
standard terminology (i.e., in this study - SNOMED CT) within a specific clinical domain (i.e. in 
this case patients’ adverse reactions) [22].   
 A “lexicon” is the vocabulary of our NLP system that is used to identify reaction terms in free-
text entries.  Our reaction lexicon contained additional terms collected from free-text that are not 
currently included in SNOMED CT. For example, in the reaction entry “he was switched from 
apap (acetaminophen) to asa (aspirin) due to elev (elevated) LFTs and cough”, we extracted the 
terms “elev LFTs” and “cough”. The term “elev LFTs” was mapped to the SNOMED CT 
concept ID 707724006 elevated liver enzymes level” (using its preferred term) along with other 
synonyms such as “LFT elevation”.  
 
We classified hypersensitivity reactions (HSRs) as immediate or non-immediate. Immediate 
HSRs have a time to onset less than one hour and are typically IgE-mediated, manifesting as 
urticaria, angioedema, rhinitis, conjunctivitis, bronchospasm, or anaphylaxis[23].  Non-
immediate HSRs have a time to onset greater than one hour and are commonly T-cell mediated, 
manifesting with cutaneous symptoms including late-onset urticaria, maculopapular eruptions, 
fixed drug eruptions, vasculitis, toxic epidermal necrolysis, Stevens–Johnson syndrome, or drug 
reaction with eosinophilia and systemic symptoms syndrome[24 25]. 
 
Setting and Corpus 
Our study used the Partners Enterprise-wide Allergy Repository (PEAR) which contains allergy 
information of all patients within the federated hospital/provider network, entered by clinicians 
in the EHR’s allergy module [26]. As of October 26th, 2014, PEAR contained 3,949,996 active 
allergy entries for 2,730,250 unique patients, including drug, food, and environmental allergens, 
where 2,315,944 (58.6%) allergens had one or more reaction entries, accounting for 2,471,004 
active allergy reaction entries. Among these reactions, 1,751,817 (70.9%) were coded entries 
(using 35 unique locally-defined codes, including “Unknown”) and 719,187 (29.1%) were free-
text entries. The average length of free-text entries was 12.1 [range 0-255] characters. Many 
free-text entries were long narratives containing other contextual information, such as “after a 
shot of PEN (penicillin), walked across the room and passed out, in childhood.” To develop our 
lexicon, we utilized a subset of our corpus consisting of all entries with a frequency greater than 
10 entries resulting in 539,610 (75.0% of total) free-text entries corresponding to 3,160 unique 
entries with an average length of 8.7 [range 0-68] characters.   
To ensure the lexicon did not miss important but rare concepts, we randomly selected a subset of 
500 reaction entries with a frequency of 10 or less (average length 22.1 [range 1-255] characters) 
for an internal evaluation. For external validation, we compared the adverse reaction value set we 
generated with two external value sets: 1) the FHIMS adverse reaction value set as described 
above; and 2) 604 unique adverse reaction concepts from the UNMC.  This study was approved 
by the Partners and University of Colorado Multiple Institutional Review Boards (IRB). 
 
Phase 1: Data Processing and Lexicon Development 
Free-text reaction entries from PEAR were processed using MTERMS[19 27]. As described in 
prior work[19 21], MTERMS uses regular expression rules and a lexicon to: 1) process and tag 
allergens and reactions; 2) correct misspellings[28]; 3) handle contextual information (negations, 
temporality, exceptions, and abbreviations); and 4) map terms to concepts within standard 
terminologies.  For this study, we mapped reaction terms in PEAR to the March 2016 release of 
the U.S. Edition of SNOMED CT[29].  Data processing and lexicon development involved 4 
steps as summarized in Figure 2 and described in detail below.  
 
Step 1: Mapping Reaction Entries to SNOMED CT Descriptions  
The first step focused on mapping PEAR reaction entries to SNOMED CT at the description 
(term) level. The terms found in this step formed the basis of our lexicon.  MTERMS processed 
all 539,610 free-text reaction entries with a frequency greater than 10 (3,160 unique entries) and 
could map them to 757 SNOMED CT descriptions in the clinical finding hierarchy. The output 
was then manually reviewed by the study authors (FG, WA, KF) and pharmacy students who 
were in their 5th year of training. Thirty-one automatically mapped terms were not reactions (e.g., 
“male”, “near”) and therefore were removed from the lexicon, yielding 726 correctly mapped 
terms. We then manually mapped 1,109 terms that were unable to be automatically mapped (e.g., 
too poorly misspelled for the spell checker or use of abbreviations, e.g., “ITP” for “idiopathic 
thrombocytopenic purpura”) to SNOMED CT. Finally, we identified four terms (itchy tongue, 
sores in throat, throat tingling and tingling in throat) that, although they represented reactions, we 
were unable to map to SNOMED CT, resulting in 1,835 terms in our lexicon. 
 
Step 2: Mapping Reaction Terms to SNOMED CT Concepts  
This step aimed to further expand the lexicon using the following three sub-steps. First we used 
MTERMS to map these 1,835 terms to their SNOMED CT concept IDs. For example, “rash” 
was mapped to two SNOMED concept IDs: 271807003 (eruption of skin (disorder)) and 
112625008 (cutaneous eruption (morphologic abnormality)), because rash is listed as a synonym 
of these two concepts. Second, we included SNOMED CT synonyms for each identified concept. 
For example, for concept ID 271807003, we included the synonyms “eruption of skin”, 
“eruption”, “exanthema”, etc. Third, we repeated the above two sub-steps until no more concept 
IDs or synonyms could be added. This resulted in 4,541 terms representing 834 concepts 
included in our lexicon. 
 
Step 3: Refining Mapping Hierarchies  
It is possible that a term was mapped to multiple concept IDs within different top-level 
hierarchies (or axes) of SNOMED CT. In the above example, “rash” was mapped to two 
concepts within two different hierarchies: disorder and morphologic abnormality; where the 
latter hierarchy is not related and therefore excluded from the lexicon. This enabled us to clean 
up the lexicon by excluding non-reaction concepts and unrelated hierarchies such as morphologic 
abnormality, qualifier value, and observable entity. At this stage, our lexicon comprised 4,300 
terms representing 782 concepts split between the disorder (47.2%, n=369) and the findings 
concepts (52.8%, n=413). 
 
Step 4: Assessing Lexicon Coverage by Processing Less Frequent Reaction Entries and Create 
Partners Value Set 
To ensure we were not missing rare reactions with lower frequencies, we examined the coverage 
of our lexicon on a random subset of 500 entries from PEAR with a frequency less than or equal 
to 10.  Using MTERMS, we processed this subset and calculated its coverage. Our lexicon 
performed well covering 96.6% of these concepts and supporting our belief that few new 
reactions were likely to be found in these longer narratives.  MTERMS mapping performance 
was strong with a precision of 98.0%, recall of 95.3% and overall F-measure of 96.6%.  With the 
addition of the four concepts we were unable to map in Step 1, the total number of concepts in 
our lexicon rose to 786 concepts.  These concepts formed the basis of our Partners Value Set 
(PVS). 
 
 
Figure 2. Adverse Reaction Lexicon Development 
 
Phase 2: Frequencies of Reaction Concepts in PEAR  
To assess the frequency of reaction concepts, we processed all reaction entries in PEAR (i.e. all 
free-text and structured entries) using MTERMS and our final lexicon. We identified in 
2,584,112 terms (1,770,418 in the coded entries and 813,694 identified in the free-text entries), 
mapped these terms to their corresponding SNOMED CT concepts in the PVS, and calculated 
the frequencies of each concept in PEAR.  We found the most frequently observed reactions 
were rash (eruption of skin) (13.96%, n=360,859), hives (weal) (8.25%, n=213,228), and 
gastrointestinal upset (irritation) (5.47%, n=141,389). A breakdown of the top 20 concepts 
between coded, free-text and overall frequency of entries is shown in Table 1 (full list in 
supplement A). Of interest, some of the most frequent concepts were only entered as free-text, 
including dizziness and palpitations.   
 Table 1: Top 20 Reaction Concepts 
Reactions 
 
SNOMED CT 
ConceptID 
Total 
Frequency 
Total 
% 
Coded 
Frequency 
Coded 
% 
Free-text 
Frequency 
Free-
text % 
Eruption of skin 
(i.e., Rash) 
271807003 360,859 
13.96 
251,840 
14.22 
109,019 
13.40 
Weal (i.e., Hives) 247472004 213,228 
8.25 
165,108 
9.33 
48,120 
5.91 
Gastrointestinal 
irritation 
95516005 141,389 
5.47 
113,323 
6.40 
28,066 
3.45 
Itching 418290006 81,462 
3.15 
67,707 
3.82 
13,755 
1.69 
Anaphylaxis 39579001 63,632 
2.46 
59,915 
3.38 
3,717 
0.46 
Nausea 422587007 45,300 
1.75 
20,035 
1.13 
25,265 
3.10 
Swelling 65124004 39,522 
1.53 
20,067 
1.13 
19,455 
2.39 
Cough 49727002 37,510 
1.45 
14,860 
0.84 
22,650 
2.78 
Vomiting 422400008 34,894 
1.35 
18,854 
1.06 
16,040 
1.97 
Angioedema 41291007 32,619 
1.26 
27,196 
1.54 
5,423 
0.67 
Altered mental 
status 
419284004 29,709 
1.15 
27,788 
1.57 
1,921 
0.24 
Dyspnea 267036007 
25,013 
0.97 
18,235 
1.03 
6,778 
0.83 
Muscle pain 68962001 23,568 
0.91 
8,539 
0.48 
15,029 
1.85 
Headache 25064002 22,534 
0.87 
8,084 
0.46 
14,450 
1.78 
Bronchospasm 4386001 18,521 
0.72 
17,934 
1.01 
587 
0.07 
Diarrhea 62315008 
18,365 
0.71 
9,106 
0.51 
9,259 
1.14 
Wheezing 56018004 
17,871 
0.69 
15,869 
0.90 
2,002 
0.25 
Sneezing 76067001 
16,856 
0.65 
11,792 
0.67 
5,064 
0.62 
Dizziness 404640003 
12,258 
0.47 
0 
0.00 
12,258 
1.51 
Palpitations 80313002 
8,724 
0.34 
0 
0.00 
8,724 
1.07 
Others - 403,556 15.62 36,664 2.07 366,892 45.09 
Unknown - 936,722 36.25 857,502 48.44 79,220 9.74 
Total - 2,584,112 100 1,770,418 100 813,694 100 
 
Comparison with Existing Reaction Value Sets 
Comparison among value sets was performed using methods that were similar to those we used 
in Zhou et al. [10], where we defined a match as exact, partial (broad or narrow) or missing. 
Broad matches in our study were defined when the terms in our lexicon were less specific than 
our target terminology (FHIMS, UNMC) (e.g., “Liver damage” -> “Cirrhosis of liver”).  Narrow 
matches were defined when the term in our lexicon was more specific than the target 
terminology (e.g. “GI upset” -> “Gastrointestinal symptom”).  Broad and Narrow matches were 
defined as involving only one reaction that could include a modifier (e.g. acute) or qualifier (e.g. 
severe).  Where two or more reactions existed within a single concept, we classified this as pre-
coordinated (e.g., nausea, vomiting and diarrhea). Both mapping and frequencies of reactions 
within the source terminology were calculated. For example, in FHIMS, there were 92 partial 
matches that were classified as broad out of total of 599 representing 15.4% of concepts.  Each 
concept is associated with a frequency in the source terminology. For example, the frequency of 
gastrointestinal symptom within UNMC was 0.113% (179 reaction entries/ 157,806 total 
reactions). These were summed across each value set and stratified by match type (Table 2).  
 
When comparing FHIMS to PVS, at the concept level, we found 321 concepts within the two 
value sets having an exact concept ID match (Table 2). At the term level, there were 59 terms 
that were an exact match (e.g., bleeding from nose -> nose bleed) but with different concept IDs. 
In total, there were 380 (321+59) exact matches, representing 63.4% of the concepts in FHIMS. 
Among partial matches, there were 92 (15.4%) concepts in FHIMS that could be mapped to a 
broader concept in our PVS value set (e.g., respiratory crackles ->respiratory symptom) and 24 
(4.2%) concepts that could be mapped to a narrower concept (e.g., serum cholesterol raised -> 
hypertriglyceridemia). There were 96 (16.0%) missing concepts where PVS did not have a match 
for the FHIMS concept. Pre-coordinated terms were small in number with 6 concepts that 
contained multiple reactions, representing 1.0% of concepts in FHIMS.  By frequency of 
documentation, the number of concepts covered by our value set was 97.48% at the exact level 
and 99.36% including partial matches. Missing concepts represented 0.09%.    
 
When comparing the UNMC reactions to PVS, at the concept level, there were 408 concepts that 
were an exact match by concept ID and 46 concepts that were an exact match at the term level. 
The total number of exact matches was 454, representing 75.2% of the concepts in UNMC. 
Among partial matches, there were 75 (12.4%) concepts in UNMC that could be could be 
mapped to a broader concept in PVS and 39 (5.1%) concepts that could be mapped to a narrower 
concept. There were 39 (6.5%) missing concepts and 5 (0.83%) pre-coordinated concepts. By 
frequency, the PVS value set covered 98.73% of concepts at the exact level and 99.78% 
including partial matches. 
 
From the 135 (96+39) unique missing concepts, there were twelve (10 from FHIMS and 2 from 
UNMC) that upon review, we believe should be excluded from the integrated reaction value set. 
Reasons for possible exclusion are shown in Table 3. 
 
Table 2: Concept coverage between PVS and FHIMS/UNMC 
Match FHIMS UNMC 
 
Examples 
 # concepts % concepts % Frequency of 
concepts 
(source 
database) 
# concepts % concepts % Frequency 
of concepts 
(source 
database) 
 
Exact Match 380 63.4 97.48 454 75.2 98.73 
 
Heart 
irregular | 
irregular 
heart beat 
Partial Broad* 92 15.4 1.55 75 12.4 0.72 Swelling of 
lower jaw 
region | face 
swelling 
Partial Narrow** 24  4.17 0.32 31 5.1 
 
0.33 Disease of 
liver | Liver 
damage 
Missing 96 16.03 0.54 39 6.5 0.16 Mass, 
Elevated INR 
Pre-coordinated 6 1.0 0.09 5 0.83 0.07  
Total (partial + exact) 496 82.97 99.35 560 92.7 99.78  
*Partial Broad: Broad matches in our study were defined when the terms in our lexicon were less specific than our target 
terminology (FHIMS, UNMC) (e.g., “Liver damage” -> “Cirrhosis of liver”). 
**Partial Narrow: Narrow matches were defined when the terms in our lexicon were more specific than the target terminology 
(e.g. “GI upset” -> “Gastrointestinal symptom”) 
 
Table 3: Reasons for possible exclusion 
Concept Source*  Frequency in Source Reason for possible exclusion 
Acute relapsing multiple 
sclerosis 
FHIMS 0% chronicity not necessary per se, 
use multiple sclerosis concept 
Traffic accident on public road FHIMS 0% event, not a clinical finding or 
disorder 
Malignant tumor of breast FHIMS 0% diagnosis, not a reaction 
Fracture of femur FHIMS 0% Pathological fracture?, result of 
fall due to adverse reaction to 
medication? 
Infectious disease FHIMS 0% too broad 
Drug intolerance FHIMS 0.0037% classification of reaction, not a 
symptom of a reaction to an 
allergen 
General health deterioration FHIMS 0% Too broad to be useful, rarely 
documented 
Patients Condition Worsened FHIMS 0% Unclear what reaction worsened 
Traumatic or non-traumatic 
injury 
FHIMS 0% Reaction type  unclear - ? fall 
Course of illness FHIMS 0% Concept is an attribute concept in 
SNOMED CT and should not be 
used to encode clinical 
information 
Infection UNMC 0.04% Too broad, rarely documented 
Treatment not tolerated UNMC 0.001% Reaction not specified, classified 
as intolerance  
*Source database: referring to FHIMS or UNMC databases. 
 
Comparison of Rare/Severe Reactions and Hypersensitivity Reactions (HSRs) 
Next we estimated the presence of severe reactions and HSRs within our value set. Severe 
reactions, while low in frequency, can be the most critical for ensuring patient safety. Using a list 
of 15 severe reactions compiled by expert review (KB, FG) in PEAR, we examined the coverage 
of the FHIMS value set and UNMC corpus on these reactions.  We found that FHIMS included 5 
out of 15 of the rare and severe reaction concepts while UNMC included 6 out of 15 concepts 
(Table 4). Common among all were Stevens-Johnson syndrome and serum sickness, 
methemoglobinemia, and neuroleptic malignant syndrome. However, other important reactions, 
such as toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms 
(DRESS), while included in PEAR, but were not present in either the FHIMS or the UNMC data 
sets. Other severe reactions absent from FHIMS and UNMC included erythema nodosum, drug-
induced hepatitis, fixed drug eruption, leukocytoclastic vasculitis, lichen planus, and aseptic 
meningitis.  
 
HSRs were classified as likely immediate or non-immediate HSRs. Within our allergy 
repository, HSRs represented 19.2% of reactions (n=150 concepts). Common HSRs are shown 
below in table 5, divided among immediate and non-immediate.   
 Table 4: Presence of severe rare reactions among value sets 
Reactions in PEAR Freq in 
PEAR% 
FHIMS* UNMC** 
Acute Interstitial Nephritis 0.0212% Yes No 
Drug reaction with eosinophilia and 
systemic symptoms (DRESS) 0.0069% 
No No 
Drug-induced hepatitis 0.0027% No No 
Erythema multiforme 0.0195% No Yes 
Erythema nodosum 0.0072% No No 
Fixed drug eruption 0.0061% No No 
Leukocytoclastic vasculitis 0.0027% No No 
Lichen planus 0.0023% No No 
Meningitis (aseptic) 0.0040% No No 
Methemoglobinemia 0.0058% Yes Yes 
Neuroleptic malignant syndrome 0.0070% Yes Yes 
Pneumonitis 0.0073% No Yes 
Serum sickness 0.0439% Yes Yes 
Stevens-Johnson Syndrome (SJS) 0.0685% Yes Yes 
Toxic Epidermal Necrolysis (TEN) 0.0104% No No 
*FHIMS: showing the presence or absence of severe reactions in FHIMS value set. 
**UNMC: showing the presence or absence of PEAR severe reactions in UNMC value set 
 
Table 5: Hypersensitivity reactions 
Immediate HSR* Non-immediate HSR** 
Anaphylaxis Serum sickness 
Hypotension Drug rash eosinophilia and systemic symptoms syndrome 
Angioedema Erythema multiforme 
Swelling Acute interstitial nephritis 
Rhinitis Fixed drug eruption 
Bronchospasm Erythema nodosum 
Asthma Stevens-Johnson syndrome 
Wheezing Toxic epidermal necrolysis 
Shortness of breath Pneumonitis 
Hives Meningitis 
Urticaria Lichenoid drug eruptions 
Itching Leukocytoclastic vasculitis  
Rash  
*Immediate HSR: Immediate HSRs (time to onset less than one hour) are typically IgE-mediated. 
**Non-immediate HSR: Non-immediate HSRs (time to onset greater than one hour) are commonly T-cell mediated, but may be 
antibody or immune-complex-mediated. 
 
Creation of an Integrated Value Set 
Lastly, from the compared value sets, we then compiled an integrated value set that combines the 
786 concepts in the PVS value set with 96 missing concepts from FHIMS and 39 missing 
UNMC concepts in addition to all the partial matches of each. In total, there were 1157 concepts.  
Each concept was manually reviewed (FG, KW, LK), duplicates removed (n=40) and excluded 
reactions above (n=12) removed, resulting in 1105 concepts. We recommend that these 1105 
reaction concepts be included in an adverse reaction value set and IDs assigned to the concepts 
we could not find a concept ID in SNOMED CT. 
 
DISCUSSION 
We created a reaction value set by processing and analyzing reaction entries contained within an 
enterprise-wide large allergy repository using a semi-automated approach of NLP followed by 
manual review. Our value set covered between 63% and 75% of reactions by exact match in 
FHIMS and UNMC respectively.  Based on frequency, these represented 97.5 to 98.7% of 
documented reactions.  Partial matches represented 17-20% of reactions and the percentage of 
missing reactions ranged from 6-16% with a higher number of missing terms in FHIMS 
compared to UNMC.  When integrated with existing value sets and curated to include missing 
concepts, partial matches, and remove ambiguous or duplicative concepts, the value set 
expanded from 786 unique concepts to 1105 reaction concepts. We believe this reaction value set 
captures the most frequently documented concepts, including severe and hypersensitivity 
reactions, collected from over two decades of documented reaction records, and that it could be a 
valuable tool for improving allergy documentation and allergy-related clinical decision support.  
  
SNOMED CT for Encoding Reactions 
We encountered several challenges during our evaluation including defining the appropriate 
hierarchy, reconciling ambiguous or duplicative concepts, and the use of the allergy section for 
documenting contraindications or religious preferences. With hierarchies, for example, a reaction 
to an allergen may include the clinical finding of irregular heart beat or the specific disorder of 
cardiac arrhythmia. While either might be correct, it would be desirable to default to one (e.g., 
clinical finding over the disorder) to avoid unintentional divergence in coding.  Duplicative 
concepts were another challenge where there may be two concepts with a similar string but with 
a different concept ID.  For example, the concept “Red Eye” was represented by two different 
concept IDs, one that referred to red eye as a “Finding of general observation of [an] eye” vs red 
eye as an “Ill-defined disorder of [the] eye”. While debatable, the former was thought to be a 
better concept both in its ontological representation and by its frequency of documentation (825 
entries vs. zero entries).  While nearly every reaction term in our lexicon had a corresponding 
concept ID, some gaps did exist.  A small number of reactions that were frequently documented 
were not present in SNOMED-CT, including ‘itchy tongue’, ‘sores in throat’, ‘throat tingling’, 
and ‘tingling in throat’.  Based on their frequency of occurrence, we would suggest adding these 
concepts, or a similar concept (e.g., oral itching) in SNOMED CT, with throat tingling and 
tingling in throat being represented as synonyms. 
 
Value set Comparison 
Overlap between PVS with FHIMS and UNMC reactions ranged between 82.9% and 92.7%. 
Manual review proved to be critical as concepts could be similar at the term level with different 
concept IDs, resulting in loss of content and coverage. One gap identified was in the coverage of 
severe reactions, which was notably lower in FHIMS and UNMC compared to PVS. These 
findings underscore the need for value sets to include severe reactions even though they may be 
low in frequency, highlighting the limitation of using frequency alone as a criterion for value set 
creation. With full representation of these rare/severe concepts in SNOMED CT, we would suggest 
including them in a reaction value set given their importance to patient safety and adverse event 
avoidance. Comparison of value sets allowed the identification of gaps present in each, their 
missing or similar concepts, and the frequency of each concepts use. After adding partial and 
missing concepts, the integrated value set added approximately 500 concepts to FHIMS and 
UNMC, suggesting that the more than half of the content between value sets is at least similar at 
the term level. At the ontology level, future efforts will be needed to ensure consistency among 
concept IDs and perhaps default to one SNOMED-CT hierarchy to avoid divergence in coding.  
 
Applications to Clinical Decision Support 
With current override rates of 90% for inpatient and 77% of outpatient allergy alerts [30-33], 
redesigning CDS for allergy alerting could not be more important. Value sets for encoding 
reactions provide the necessary discrete data to re-align the type of CDS alert for a potential 
allergy or adverse reaction. This is particularly true for immune mediated responses which are 
associated with high risk. We found nearly 20% of reactions within our value set were HSRs 
(immediate and non-immediate). This estimate of HSR reactions may be conservative as 
reactions by themselves may not represent an HSR reaction but in combination with other 
reactions can be an HSR.  For example, the GI symptoms nausea, vomiting, and diarrhea, in 
combination with shortness of breath may represent anaphylaxis (an HSR).  Serum sickness may 
be described by the combination of fever, myalgias, arthralgias, and rash. Surveillance for 
reaction documentation for patterns can help clinicians identify rare but important reactions. 
Better understanding of the immunologic nature of a reaction (e.g. HSR) can help inform the 
type of alert to be presented to the clinician. 
 
Documentation frequency of allergies can also be valuable for CDS.  With known frequencies of 
reactions in PEAR and other value sets (FHIMS, UNMC), EHRs could conceivably populate a 
dynamic reaction quick pick list based on the most commonly associated reactions for a 
particular allergen. Using a data-driven approach to populate the reaction list could help limit the 
amount of time the clinician spends searching for a specific reaction, improve accuracy of 
documentation, and reduce inappropriate downstream alerting. The ideal EHR CDS module 
would know the most probable reactions for a given allergen, tier the allergy alerts based on: the 
reaction entered, severity, and prior results from allergy testing (skin tests, challenge results), and 
allow exceptions to account for medications previously tolerated or not cross-reactive. 
Contraindications would be handled using simple rule based advisories that could be triggered 
from any discrete data in the patient’s record, be it religious preference, surgical history, or a 
problem on the patients problem list.  Robust value sets for encoding patient reactions to 
allergens we believe are key to developing the infrastructure necessary to achieve a more 
intelligent advisory and alerting system for allergy and adverse reactions, limiting alert fatigue.  
 
CONCLUSION  
We processed and encoded reactions contained within a large allergy repository to validate and 
inform the maintenance of the Adverse Clinical Reaction value set maintained by the NLM and 
VSAC for interoperable use by EHRs. Our value set in addition to FHIMS will provide new 
insights into reaction and allergen associations, innovative CDS solutions for designing more 
intelligent allergy alerting, and improved allergy documentation. 
 
Limitations  
This work may be limited by the particular demographic of the population, which was primarily 
localized to the New England area. Allergens, particularly exposure to food and environmental 
allergens in this area may be different than those in other localities. While our reaction value set 
contains the majority of reactions within PEAR, our lexicon was limited to those types of 
adverse reactions documented as free-text in the allergy module of the EHR.  Other types of 
adverse reactions contained outside the EHR or in clinical notes may differ and enrich the 
reactions documented within in the allergy module.   
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